FOSUN HEALTH Logo

Brain Glioma FAQ

catalogue

Brain Glioma FAQ

Brain Glioma FAQ

The questions on this page come after the medical ones have been answered — what treatment will cost, how long the patient will be away from home, which drugs can actually be given here, and what happens on return. They are answered separately on purpose, because glioma treatment is a sequence with phases that take place in different settings, and knowing which phase needs to happen where is what makes the arrangements workable.

What treatment costs

Treatment in China typically costs 30% to 50% of the equivalent in Europe or the United States. The total depends on which parts of the pathway you need:

  • Imaging and diagnosis — MRI with the functional sequences used for planning, any stereotactic biopsy, the neuropathology report and the molecular panel; modest individually, and the basis of every decision that follows.
  • Surgery — the operation itself, including awake craniotomy or intraoperative monitoring where these are needed, and the postoperative intensive care that some patients require.
  • Radiotherapy — priced by the course rather than by the session, and planned individually; the planning imaging and the dose shaping are part of it.
  • Drug treatment — oral chemotherapy taken over months, the anti-epileptic medication and steroids that continue alongside it, and any targeted drug, which is counted monthly.
  • Rehabilitation and supportive care — physiotherapy, speech therapy and cognitive support, which are the part of the plan that determines how much function is recovered, and which continue after the acute treatment ends.

How long you will need to stay

The length of a stay is determined by which phase of treatment you are in rather than by any general rule:

  • Assessment and planning — usually about one week, including the imaging needed for surgical planning and, where relevant, functional MRI and tractography.
  • Surgery — an inpatient stay of roughly one to two weeks, longer if intensive care or rehabilitation is needed in the first days afterwards.
  • Radiotherapy — several weeks of daily treatment, given as an outpatient; most patients stay locally and attend each weekday rather than being admitted.
  • Oral chemotherapy — taken at home, with blood tests; this phase can be supervised locally with results sent to us rather than requiring a stay in China.
  • Rehabilitation — planned from the start and continued after the acute phases, either here or locally with a written programme to follow.

Which medicines are available

Most medicines used in glioma internationally are available here:

  • Temozolomide — the oral chemotherapy used during and after radiotherapy for glioblastoma and IDH-mutant astrocytoma, taken as a capsule at home.
  • The PCV combination — procarbazine, lomustine and vincristine — and lomustine used alone, for oligodendroglioma and at recurrence.
  • An oral IDH inhibitor — available for selected patients with a slower-growing IDH-mutant glioma, subject to the tumour's molecular profile.
  • Tumour treating fields — the scalp array system used after radiotherapy in glioblastoma, where it is considered appropriate.
  • Bevacizumab — used mainly to reduce swelling and symptoms in recurrent disease.
  • Steroids and anti-epileptic drugs — including the range needed to control seizures and manage swelling, with monitoring for interactions between them.

Sending records and receiving a written opinion

The most useful thing to send is the original documents and the images rather than a summary:

  • The neuropathology report with the molecular panel — the tumour type, the grade and the markers. This is the document that defines the diagnosis, so it should be sent in full rather than as a conclusion.
  • The operative report, together with the MRI taken after surgery, which records how much tumour remains.
  • The radiotherapy plan with the dose, the number of fractions and the target volumes, if treatment has already begun or been completed.
  • The MRI images themselves, or a link to them — the report describes them, but the images are needed to judge what is treatable and how, and to compare with what follows.
  • The drug history — what was given, at what dose, for how long, and the response, together with the current steroids and anti-epileptics.

Insurance and payment

Coverage for glioma needs checking in specific terms, because the treatment is spread across several different settings:

  • Check whether the policy covers treatment outside your country of residence before assuming it does, and whether prior authorisation is required for each phase.
  • Check surgery and intensive care cover specifically, since the cost of an operation with a stay in intensive care is very different from the cost of the operation alone.
  • Check radiotherapy and rehabilitation separately — rehabilitation in particular is often limited or excluded, despite being the part of the plan that determines functional recovery.
  • Check the drug cover for oral chemotherapy and any targeted agent, which are priced monthly and handled differently from inpatient care.
  • Ask whether direct billing is available for your insurer, and request the documentation they require at the outset — a treatment plan, an estimate and clinical justification take time to assemble.

After treatment, and back home

Because glioma treatment is a sequence, the handover document matters more here than in most conditions:

  • A written summary of what was actually done — the operation and its extent, the radiotherapy dose and target volumes, the drugs with dates, and the imaging taken at the end of each phase.
  • A monitoring schedule with defined intervals — when the next MRI is due, how the intervals widen, and what change would prompt an earlier scan.
  • The steroid reduction plan — the dose, the intended taper and the symptoms that would mean it should be reviewed rather than continued.
  • Seizure and medication guidance — the anti-epileptic, the monitoring required, and the interaction issues to avoid, together with driving and safety advice.
  • A rehabilitation programme — physiotherapy, speech and cognitive exercises to continue locally, with the goals stated, since gains continue for months after treatment ends.
  • A named contact, for questions between scans and for a video review of imaging taken elsewhere.

Eating, activity and daily life during treatment

No diet treats a glioma. What nutrition and daily life can do is support you through treatment and protect function:

  • Adequate protein and calories to maintain weight, because steroids increase appetite and blood sugar while surgery and radiotherapy increase the body's needs.
  • Food safety during chemotherapy — avoiding unpasteurised dairy, raw or undercooked meat, eggs and seafood, and unwashed produce, since the blood count is suppressed during treatment.
  • Care with blood sugar on steroids — monitoring and, where needed, treatment for raised glucose, which is common and manageable rather than a reason to stop the steroid abruptly.
  • Activity adapted to function — guided by physiotherapy, because keeping moving reduces clot risk and supports recovery, while seizure and balance considerations may limit what is safe.

Frequently Asked Questions

How much does brain glioma treatment cost in China?

Treatment in China typically costs 30% to 50% of the equivalent in Europe or the United States. The total depends on which phases you need: surgery with the planning imaging and, where required, intensive care; radiotherapy priced by the course rather than the session; oral chemotherapy counted monthly together with steroids and anti-epileptic drugs; and rehabilitation, which continues after the acute phases. A formal itemised estimate is prepared from your own records and your proposed plan, and it is worth asking for the rehabilitation and drug phases separately rather than as a single figure.

How long will I need to stay in China?

The assessment and surgical planning usually take about a week. Surgery involves an inpatient stay of roughly one to two weeks, longer if intensive care or early rehabilitation is needed. Radiotherapy runs for several weeks of daily outpatient treatment, so most patients stay nearby and attend each weekday. Oral chemotherapy is taken at home with blood tests, and this phase can be supervised locally with results sent to us. A single visit covering surgery and radiotherapy planning is common, with the chemotherapy phase continued closer to home.

Are the same glioma drugs available as in my own country?

Most are. Temozolomide, the PCV combination, lomustine, bevacizumab, steroids and the range of anti-epileptic drugs are all available in our network, as are tumour treating fields and an oral IDH inhibitor for selected patients with an IDH-mutant tumour. Availability of a specific product depends on the hospital and the indication, so it should be confirmed in writing as part of the plan. If an agent approved elsewhere is not available here, ask what the realistic alternative is — usually a drug of the same class, and the substitution is routine.

What should I bring, and what should I take home?

Bring the neuropathology report with the molecular panel, the operative report, the preoperative and postoperative MRI images or a link to them, the radiotherapy plan if treatment has started, and the drug history with dates and doses. Take home a written summary of what was done, an MRI schedule with dates, the steroid reduction plan, seizure and medication guidance including driving advice, and a rehabilitation programme to continue locally. In a disease monitored over years, the record of what was treated and what the imaging showed is the most useful document you can hold.

Can follow-up be done remotely after I return home?

Partly, and it is worth planning for. Reviewing imaging, adjusting medication, and deciding when the next scan is due can all be done remotely, arranged through a named contact rather than a general enquiry line. An MRI taken locally can be sent to us for comparison with the previous studies, which is how most patients conduct the long monitoring phase. Anything requiring an examination, a procedure, an infusion or further surgery has to be done in person, and those points should be identified in advance so that travel can be planned.

What if the tumour comes back, or does not respond?

There is usually a defined next step rather than a single standard one. The first question is whether a change on the scan is true progression or the effect of radiotherapy, which is settled with perfusion imaging, spectroscopy or a repeat scan at a short interval. If it is progression, the options include further surgery if the site allows, re-irradiation in selected cases, a change of drug treatment, or bevacizumab where swelling is the main problem. Retesting the molecular profile at recurrence is increasingly worthwhile, because a tumour can acquire new findings that make a treatment relevant which was not before.

Ask before you commit to a treatment plan

Send the neuropathology and molecular report, the operative report, the MRI reports with images, the radiotherapy plan if given, and the current medication. Our international patient team will return a written assessment within 48 hours of the file being complete, with an itemised estimate on request.

Want to see the whole process first? Your full medical journey, step by step →

Book an Appointment Request a Video Consultation

Follow Fosun Health

Apply for an Appointment

Do you have test results*